Your institution may have access to this item. Find your institution then sign in to continue.
Title
Bayer to take €2.2bn charge amid restructuring.
Abstract
Reports on the announcement of German chemicals group Bayer, that it is to take an impairment charge as part of its restructuring effort. Details of the impairment charge; Rating given by British analyst Panmure to the company; Information on the consolidation of the research facilities of Bayer.